KOP (Koppers Holdings, Inc.) Stock Analysis - Financials

Koppers Holdings, Inc. (KOP) is a publicly traded Basic Materials sector company. As of May 21, 2026, KOP trades at $39.20 with a market cap of $776.77M and a P/E ratio of 10.04. KOP moved +2.17% today. Year to date, KOP is +45.56%; over the trailing twelve months it is +24.64%. Its 52-week range spans $22.99 to $46.40. Analyst consensus is buy with an average price target of $55.00. Rallies surfaces KOP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are KOP's key financials?

KOP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KOP recently traded at $39.20. Market cap is $776.77M. P/E ratio is 10.04. Revenue is $1.88B.

KOP Key Metrics

Key financial metrics for KOP
MetricValue
Price$39.20
Market Cap$776.77M
P/E Ratio10.04
EPS$3.90
Dividend Yield0.09%
52-Week High$46.40
52-Week Low$22.99
Volume0
Avg Volume0
Revenue (TTM)$1.88B
Net Income$77.00M
Gross Margin22.82%

KOP Annual Financials

YearRevenueNet IncomeEPS
2025$1.88B$56.00M$2.82
2023$2.15B$89.80M$4.28
2022$1.98B$63.20M$3.02
2021$1.68B$84.90M$4.00

Latest KOP News

Recent KOP Insider Trades

  • BALL M LEROY sold 2.66K (~$113.14K) on May 13, 2026.
  • BALL M LEROY sold 2.49K (~$94.36K) on Mar 17, 2026.
  • BALL M LEROY sold 2.18K (~$79.78K) on Mar 2, 2026.

KOP Analyst Consensus

1 analysts cover KOP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $55.00.

Common questions about KOP

What are KOP's key financials?
KOP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KOP recently traded at $39.20. Market cap is $776.77M. P/E ratio is 10.04. Revenue is $1.88B.
Is KOP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KOP. It does not provide personalized investment advice.
KOP

KOP